WallStreetZenWallStreetZen

NASDAQ: ORGS
Orgenesis Inc Earnings & Revenue

ORGS past earnings growth

How has ORGS's earnings growth performed historically?
Company
6.15%
Industry
23.48%
Market
117.86%
ORGS's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
ORGS's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
ORGS's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

ORGS past revenue growth

How has ORGS's revenue growth performed historically?
Company
-98.17%
Industry
83.05%
Market
15.22%
ORGS's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ORGS's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

ORGS earnings and revenue history

Current Revenue
$529.0k
Current Earnings
-$45.7M
Current Profit Margin
-8,630.6%

ORGS Return on Equity

Current Company
N/A
Current Industry
16.7%
Current Market
28.2%

Be the first to know when ORGS announces earnings.

ORGS Return on Assets

Current Company
-225.3%
Current Industry
3.2%
ORGS is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ORGS Return on Capital Employed

Current Company
-2,256.54%
Current Industry
-43.6%
ORGS's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ORGS vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ORGS$529.00k-$41.26M-$45.66M-43.95%-83.72%
SYBX$3.21M-$68.01M-$73.22M+5.06%N/A
PHGE$0.00-$22.87M-$26.17MN/AN/A
APTO$0.00-$46.73M-$47.17MN/AN/A
GLYC$10.00k-$36.35M-$37.28M-81.74%N/A

Orgenesis Earnings & Revenue FAQ

What were ORGS's earnings last quarter?

On Invalid Date, Orgenesis (NASDAQ: ORGS) reported Q1 2024 earnings per share (EPS) of $0.29, up 66.67% year over year. Total Orgenesis earnings for the quarter were -$9.77 million. In the same quarter last year, Orgenesis's earnings per share (EPS) was $0.87.

If you're new to stock investing, here's how to buy Orgenesis stock.

What was ORGS's earnings growth in the past year?

As of Q2 2024, Orgenesis's earnings has grown 6.15% year over year. This is 17.33 percentage points lower than the US Biotechnology industry earnings growth rate of 23.48%. Orgenesis's earnings in the past year totalled -$45.66 million.

What was ORGS's revenue last quarter?

On Invalid Date, Orgenesis (NASDAQ: ORGS) reported Q1 2024 revenue of $141.00 thousand up 0.7% year over year. In the same quarter last year, Orgenesis's revenue was $142.00 thousand.

What was ORGS's revenue growth in the past year?

As of Q2 2024, Orgenesis's revenue has grown -98.17% year over year. This is 181.22 percentage points lower than the US Biotechnology industry revenue growth rate of 83.05%. Orgenesis's revenue in the past year totalled $529.00 thousand.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.